GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » Common Stock

Concord Drugs (BOM:538965) Common Stock : ₹0.0 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs Common Stock?

Concord Drugs's quarterly common stock increased from Jun. 2023 (₹0.0 Mil) to Sep. 2023 (₹93.2 Mil) but then declined from Sep. 2023 (₹93.2 Mil) to Dec. 2023 (₹0.0 Mil).

Concord Drugs's annual common stock stayed the same from Mar. 2021 (₹87.4 Mil) to Mar. 2022 (₹87.4 Mil) but then increased from Mar. 2022 (₹87.4 Mil) to Mar. 2023 (₹93.2 Mil).


Concord Drugs Common Stock Historical Data

The historical data trend for Concord Drugs's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs Common Stock Chart

Concord Drugs Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78.62 87.44 87.44 87.44 93.16

Concord Drugs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 93.16 - 93.16 -

Concord Drugs Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Concord Drugs (BOM:538965) Business Description

Traded in Other Exchanges
N/A
Address
3-11-451, L B Nagar, Hayatnagar Mandal, Hyderabad, TG, IND, 500074
Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers. Geographically, it operates only in India.

Concord Drugs (BOM:538965) Headlines

No Headlines